Sanofi Sponsored ADR is a company in the U.S. stock market and it is a holding in 15 U.S.-traded ETFs. SNY has around 3.8M shares in the U.S. ETF market. The largest ETF holder of SNY is the iShares NASDAQ Biotechnology ETF (IBB), with approximately 2.29M shares. Investors may also find of interest that the ETF with the largest allocation to SNY stock is VanEck Vectors Pharmaceutical ETF (PPH), with a portfolio weight of 5.07%. On average, U.S. ETFs allocate 1.44% of SNY to their portfolios.
Additionally, SNY is a favorite stock for Active and Exchange-specific ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with SNY as a holding is the ProShares Ultra NASDAQ Biotechnology (BIB), with a return of 50.24%.